Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
36
RARE Quote, Financials, Valuation and Earnings
Last price:
$34.57
Seasonality move
:
-0.96%
Day range:
$34.07 - $34.89
52-week range:
$25.81 - $46.50
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.28x
P/B ratio:
359.51x
Volume:
841.3K
Avg. volume:
1.4M
1-year change:
-22.2%
Market cap:
$3.3B
Revenue:
$560.2M
EPS (TTM):
-$5.94
Earnings Data
Next earnings date for RARE
Feb 12
2026
Most recent earnings per share
-$1.81
Missed by $0.60
(Nov 4/2025)
Consensus Estimate
-$1.21
(Nov 4/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RARE Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/12/2026 | Q4 | $188M | -- | -- | -$1.23 | -- |
| 11/04/2025 | Q3 | $166.8M | $159.9M | -$1.81 | -$1.21 | -$0.60 |
| 08/05/2025 | Q2 | $161.4M | $166.5M | -$1.17 | -$1.32 | $0.15 |
| 05/01/2025 | Q1 | $144.5M | $139.3M | -$1.57 | -$1.64 | $0.07 |
| 02/13/2025 | Q4 | $158.7M | $164.9M | -$1.39 | -$1.27 | -$0.12 |
| 11/05/2024 | Q3 | $135.2M | $139.5M | -$1.40 | -$1.47 | $0.07 |
| 08/01/2024 | Q2 | $123.2M | $147M | -$1.52 | -$1.63 | $0.11 |
| 05/02/2024 | Q1 | $116.4M | $108.8M | -$2.03 | -$1.72 | -$0.30 |
| 02/15/2024 | Q4 | $121M | $127.4M | -$1.52 | -$1.61 | $0.09 |
| 11/02/2023 | Q3 | -- | $98.1M | -$2.23 | -- | -- |
| 08/03/2023 | Q2 | -- | $108.3M | -$2.25 | -- | -- |
| 05/04/2023 | Q1 | -- | $100.5M | -$2.33 | -- | -- |
| 02/16/2023 | Q4 | -- | $103.3M | -$2.16 | -- | -- |
| 11/02/2022 | Q3 | -- | $90.7M | -$3.50 | -- | -- |
| 07/28/2022 | Q2 | -- | $89.3M | -$2.26 | -- | -- |
| 05/05/2022 | Q1 | -- | $79.9M | -$2.19 | -- | -- |
| 02/10/2022 | Q4 | -- | $83.4M | -$1.79 | -- | -- |
| 11/02/2021 | Q3 | -- | $81.6M | -$1.08 | -- | -- |
| 08/02/2021 | Q2 | -- | $87M | -$1.81 | -- | -- |
| 05/04/2021 | Q1 | -- | $99.4M | -$2.03 | -- | -- |
| 02/11/2021 | Q4 | -- | $91.5M | -$0.37 | -- | -- |
| 10/27/2020 | Q3 | -- | $81.5M | -$1.13 | -- | -- |
| 07/30/2020 | Q2 | -- | $61.7M | $0.41 | -- | -- |
| 05/06/2020 | Q1 | -- | $36.3M | -$2.05 | -- | -- |
| 02/13/2020 | Q4 | -- | $35.6M | -$1.62 | -- | -- |
| 11/05/2019 | Q3 | -- | $25.8M | -$1.96 | -- | -- |
| 08/01/2019 | Q2 | -- | $24.1M | -$1.72 | -- | -- |
| 05/06/2019 | Q1 | -- | $18.2M | -$1.82 | -- | -- |
| 02/19/2019 | Q4 | -- | $16.3M | -$1.73 | -- | -- |
| 11/05/2018 | Q3 | -- | $11.8M | -$1.74 | -- | -- |
| 08/02/2018 | Q2 | -- | $12.8M | -$1.06 | -- | -- |
| 05/07/2018 | Q1 | -- | $10.7M | $0.62 | -- | -- |
| 02/20/2018 | Q4 | -- | $2.4M | -$1.89 | -- | -- |
| 11/02/2017 | Q3 | -- | $198K | -$1.87 | -- | -- |
| 07/27/2017 | Q2 | -- | -- | -$1.72 | -- | -- |
| 05/08/2017 | Q1 | -- | -- | -$1.63 | -- | -- |
| 02/16/2017 | Q4 | -- | $5K | -$1.75 | -- | -- |
| 11/07/2016 | Q3 | -- | $111K | -$1.64 | -- | -- |
| 08/09/2016 | Q2 | -- | $17K | -$1.46 | -- | -- |
| 05/09/2016 | Q1 | -- | -- | -$1.35 | -- | -- |
| 02/25/2016 | Q4 | -- | -- | -$1.42 | -- | -- |
Ultragenyx Pharmaceutical, Inc. Earnings Questions
-
How Much did Ultragenyx Pharmaceutical, Inc. Generate in Revenue Last Quarter?
Ultragenyx Pharmaceutical, Inc. reported $159.9M worth of top line sales in its most recent quarter.
-
Did Ultragenyx Pharmaceutical, Inc. Beat Earnings Last Quarter?
Ultragenyx Pharmaceutical, Inc. announced earnings per share of -$1.81 which represents a miss of analyst forecast a -$1.21 per share.
-
Is Ultragenyx Pharmaceutical, Inc. Profitable?
Ultragenyx Pharmaceutical, Inc. reported $123.3M that represents $1.24 per share over the last quarter.
-
What is the Analyst Consensus for Ultragenyx Pharmaceutical, Inc. EPS Next Year?
Ultragenyx Pharmaceutical, Inc.'s earnings are forecast to decrease from -$6.29 per share to -$6.17 per share next year representing a decrease of -8.19%.
-
When is Ultragenyx Pharmaceutical, Inc.'s Earnings Date?
Ultragenyx Pharmaceutical, Inc.'s next earnings date is February 12, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 24
Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
